32 related articles for article (PubMed ID: 8794902)
1. The acidified drinking water-induced changes in the behavior and gut microbiota of wild-type mice depend on the acidification mode.
Whipple B; Agar J; Zhao J; Pearce DA; Kovács AD
Sci Rep; 2021 Feb; 11(1):2877. PubMed ID: 33536529
[TBL] [Abstract][Full Text] [Related]
2. Annexin A1 Regulates NLRP3 Inflammasome Activation and Modifies Lipid Release Profile in Isolated Peritoneal Macrophages.
Sanches JM; Branco LM; Duarte GHB; Oliani SM; Bortoluci KR; Moreira V; Gil CD
Cells; 2020 Apr; 9(4):. PubMed ID: 32283822
[TBL] [Abstract][Full Text] [Related]
3. LPA receptor signaling: pharmacology, physiology, and pathophysiology.
Yung YC; Stoddard NC; Chun J
J Lipid Res; 2014 Jul; 55(7):1192-214. PubMed ID: 24643338
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors.
Im DS
Acta Pharmacol Sin; 2010 Sep; 31(9):1213-22. PubMed ID: 20729877
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin.
Khandoga AL; Fujiwara Y; Goyal P; Pandey D; Tsukahara R; Bolen A; Guo H; Wilke N; Liu J; Valentine WJ; Durgam GG; Miller DD; Jiang G; Prestwich GD; Tigyi G; Siess W
Platelets; 2008 Sep; 19(6):415-27. PubMed ID: 18925509
[TBL] [Abstract][Full Text] [Related]
6. Lysophospholipid signaling: beyond the EDGs.
Valentine WJ; Fujiwara Y; Tsukahara R; Tigyi G
Biochim Biophys Acta; 2008 Mar; 1780(3):597-605. PubMed ID: 17931789
[TBL] [Abstract][Full Text] [Related]
7. A lysophosphatidic acid analogue is revealed as a potent inhibitor of phosphatidylcholine synthesis, inducing apoptosis.
Gueguen G; Granci V; Rogalle P; Briand-Mésange F; Wilson M; Klaébé A; Tercé F; Chap H; Salles JP; Simon MF; Gaits F
Biochem J; 2002 Dec; 368(Pt 2):447-59. PubMed ID: 12197836
[TBL] [Abstract][Full Text] [Related]
8. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.
Tokumura A; Sinomiya J; Kishimoto S; Tanaka T; Kogure K; Sugiura T; Satouchi K; Waku K; Fukuzawa K
Biochem J; 2002 Aug; 365(Pt 3):617-28. PubMed ID: 11982483
[TBL] [Abstract][Full Text] [Related]
9. Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils.
Leitinger N; Tyner TR; Oslund L; Rizza C; Subbanagounder G; Lee H; Shih PT; Mackman N; Tigyi G; Territo MC; Berliner JA; Vora DK
Proc Natl Acad Sci U S A; 1999 Oct; 96(21):12010-5. PubMed ID: 10518567
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions.
Siess W; Zangl KJ; Essler M; Bauer M; Brandl R; Corrinth C; Bittman R; Tigyi G; Aepfelbacher M
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6931-6. PubMed ID: 10359816
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning of a high-affinity receptor for the growth factor-like lipid mediator lysophosphatidic acid from Xenopus oocytes.
Guo Z; Liliom K; Fischer DJ; Bathurst IC; Tomei LD; Kiefer MC; Tigyi G
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14367-72. PubMed ID: 8962057
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of lipid phosphatidate receptors: N-palmitoyl-serine and N-palmitoyl-tyrosine phosphoric acids.
Bittman R; Swords B; Liliom K; Tigyi G
J Lipid Res; 1996 Feb; 37(2):391-8. PubMed ID: 9026536
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation.
Gueguen G; Gaigé B; Grévy JM; Rogalle P; Bellan J; Wilson M; Klaébé A; Pont F; Simon MF; Chap H
Biochemistry; 1999 Jun; 38(26):8440-50. PubMed ID: 10387090
[TBL] [Abstract][Full Text] [Related]
14. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
Oz M; Zhang L; Rotondo A; Sun H; Morales M
Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
[TBL] [Abstract][Full Text] [Related]
15. Stereochemical properties of lysophosphatidic acid receptor activation and metabolism.
Yokoyama K; Baker DL; Virag T; Liliom K; Byun HS; Tigyi G; Bittman R
Biochim Biophys Acta; 2002 May; 1582(1-3):295-308. PubMed ID: 12069841
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis for lysophosphatidic acid receptor antagonist selectivity.
Sardar VM; Bautista DL; Fischer DJ; Yokoyama K; Nusser N; Virag T; Wang DA; Baker DL; Tigyi G; Parrill AL
Biochim Biophys Acta; 2002 May; 1582(1-3):309-17. PubMed ID: 12069842
[TBL] [Abstract][Full Text] [Related]
17. N-palmitoyl-serine and N-palmitoyl-tyrosine phosphoric acids are selective competitive antagonists of the lysophosphatidic acid receptors.
Liliom K; Bittman R; Swords B; Tigyi G
Mol Pharmacol; 1996 Sep; 50(3):616-23. PubMed ID: 8794902
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
